HK1104220A1 - Pre-formulation for the tabletting of natural mixtures of conjugated estrogens - Google Patents

Pre-formulation for the tabletting of natural mixtures of conjugated estrogens

Info

Publication number
HK1104220A1
HK1104220A1 HK07109383.9A HK07109383A HK1104220A1 HK 1104220 A1 HK1104220 A1 HK 1104220A1 HK 07109383 A HK07109383 A HK 07109383A HK 1104220 A1 HK1104220 A1 HK 1104220A1
Authority
HK
Hong Kong
Prior art keywords
tabletting
formulation
conjugated estrogens
natural mixtures
mixtures
Prior art date
Application number
HK07109383.9A
Inventor
B Thumbeck
I Bonnacker
M Lerch
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1104220A1 publication Critical patent/HK1104220A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07109383.9A 2001-12-14 2007-08-28 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens HK1104220A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01129840 2001-12-14

Publications (1)

Publication Number Publication Date
HK1104220A1 true HK1104220A1 (en) 2008-01-11

Family

ID=8179550

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05107341A HK1075007A1 (en) 2001-12-14 2005-08-22 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
HK07109383.9A HK1104220A1 (en) 2001-12-14 2007-08-28 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK05107341A HK1075007A1 (en) 2001-12-14 2005-08-22 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens

Country Status (14)

Country Link
US (2) US8273728B2 (en)
EP (1) EP1458363B1 (en)
JP (1) JP4695838B2 (en)
CN (2) CN100502839C (en)
AR (1) AR037642A1 (en)
AU (1) AU2002358682B2 (en)
BR (1) BR0214954A (en)
CA (1) CA2470209A1 (en)
ES (1) ES2403218T3 (en)
HK (2) HK1075007A1 (en)
MX (1) MXPA04005767A (en)
PL (1) PL205544B1 (en)
TW (1) TWI332400B (en)
WO (1) WO2003051337A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9586335B2 (en) * 2010-01-27 2017-03-07 Sd3, Llc Blade guard with dust collection
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
US8349819B2 (en) 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
WO2011008674A1 (en) * 2009-07-16 2011-01-20 Mallinckrodt Baker, Inc. Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (en) 2011-11-23 2021-12-14 Therapeuticsmd, Inc A PHARMACEUTICAL COMPOSITION COMPRISING SOLUBILIZED ESTRADIOL, PROGESTERONE AND A SOLUBILIZING AGENT, AND USES THEREOF TO TREAT A MENOPAUSE-RELATED SYMPTOM IN A WOMAN
EP2787987B1 (en) * 2011-12-08 2016-06-01 Hexal AG New pharmaceutical statin compositions
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
BR112018070199A2 (en) 2016-04-01 2019-01-29 Therapeuticsmd Inc pharmaceutical composition of steroid hormone
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2021162906A1 (en) * 2020-02-11 2021-08-19 Sheh Fung Screws Co., Ltd Fastener having improved wobble control, fastening system including the same, and method of forming the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
DE3535536A1 (en) * 1985-10-04 1987-04-09 Lentia Gmbh METHOD FOR SIMULTANEOUS DRYING AND GRANULATING EXTRACT MATERIALS FROM DEFROSTED CALF BLOOD
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
DK0923381T3 (en) 1996-08-30 2004-05-10 Solvay Pharm Gmbh Process for producing estrogens from hops urine
PL185920B1 (en) 1996-08-30 2003-08-29 Solvay Pharm Gmbh Method of obtaining estrogens from mare's urine
US6200289B1 (en) 1998-04-10 2001-03-13 Milestone Scientific, Inc. Pressure/force computer controlled drug delivery system and the like
JP2000156938A (en) 1998-11-19 2000-06-06 Hokuto Denko Kk Charge/discharge tester for battery
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens

Also Published As

Publication number Publication date
CN1607944A (en) 2005-04-20
US20050009800A1 (en) 2005-01-13
TW200408400A (en) 2004-06-01
AR037642A1 (en) 2004-11-17
CN1977862A (en) 2007-06-13
EP1458363B1 (en) 2013-01-16
MXPA04005767A (en) 2004-09-10
JP4695838B2 (en) 2011-06-08
ES2403218T3 (en) 2013-05-16
CN1298313C (en) 2007-02-07
PL205544B1 (en) 2010-04-30
US20120237666A1 (en) 2012-09-20
EP1458363A1 (en) 2004-09-22
AU2002358682B2 (en) 2009-03-26
PL368730A1 (en) 2005-04-04
AU2002358682A1 (en) 2003-06-30
TWI332400B (en) 2010-11-01
CN100502839C (en) 2009-06-24
CA2470209A1 (en) 2003-06-26
BR0214954A (en) 2004-12-14
US8273728B2 (en) 2012-09-25
US8329679B2 (en) 2012-12-11
JP2005516923A (en) 2005-06-09
WO2003051337A1 (en) 2003-06-26
HK1075007A1 (en) 2005-12-02

Similar Documents

Publication Publication Date Title
HK1075007A1 (en) Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
HK1150021A1 (en) Fulvestrant formulation fulvestrant
GB0023983D0 (en) Therapeutic compounds
GB0008710D0 (en) Therapeutic compounds
GB0016681D0 (en) Therapeutic compounds
GB0020691D0 (en) Pharmaceutical combination
HK1057474A1 (en) Medicinal composition
GB0012291D0 (en) Pharmaceutical combination
GB0012293D0 (en) Pharmaceutical combination
GB0013105D0 (en) Therapeutic compounds
GB0022521D0 (en) Medicinal compounds
GB0007628D0 (en) Medicinal compounds
GB0122201D0 (en) Medicinal compounds
GB0127024D0 (en) Medicinal compounds
GB0105740D0 (en) Medicinal compounds
GB0105741D0 (en) Medicinal compounds
GB0126997D0 (en) Medicinal Compounds
GB0017666D0 (en) Pharmaceutical combination
GB0017668D0 (en) Pharmaceutical combination
GB0020769D0 (en) Pharmaceutical combination
GB0020767D0 (en) Pharmaceutical combination
GB0016428D0 (en) Pharmaceutical combination
GB0020768D0 (en) Pharmaceutical combination
GB0016427D0 (en) Pharmaceutical combination
GB0016426D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141212